GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (XSWX:ACHI) » Definitions » Construction In Progress

Achiko AG (XSWX:ACHI) Construction In Progress : CHF0.00 Mil (As of Jun. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Achiko AG Construction In Progress?

Achiko AG Construction In Progress Historical Data

The historical data trend for Achiko AG's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Construction In Progress Chart

Achiko AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21
Construction In Progress
- - - -

Achiko AG Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Construction In Progress Get a 7-Day Free Trial - - - - -

Achiko AG Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Achiko AG (XSWX:ACHI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (XSWX:ACHI) » Definitions » Construction In Progress
Comparable Companies
SZSE:300869 SZSE:300314 SZSE:300246 SZSE:300633 SZSE:301033 SZSE:300813 SHSE:688016 SZSE:300206 SZSE:301235 SHSE:688389 CERN VEEV TSE:2413 CHNG DOCS NUTX RCM TDOC TXG HQY
Traded in Other Exchanges
N/A
Address
Tessinerplatz 7, Zurich, CHE, CH-8002
Website
https://www.achiko.com
Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.

Achiko AG (XSWX:ACHI) Headlines

No Headlines